Johnson & Johnson (JNJ): Talc Re-filing Settlement Cost Slightly Better than Our Expectation, 50/50 Chance It Goes Through - Wells Fargo
Tweet Send to a Friend
Wells Fargo analyst Larry Biegelsen reiterated an Overweight rating and $195.00 price target on Johnson & Johnson (NYSE: JNJ)."On ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
